In the ITT population, 91 patients received a first-line and 48 patients received a second-line chemotherapy or higher; 89 patients were treated with a TX, 45 patients with a GX, and 5 patients with an NX combination chemotherapy
Our study compared referral and treatment rates of neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer before and after publication of a CPG recommending cisplatin-based combination chemotherapy
Also, the difference in toxicity profile between the 2 agents makes the combination a good candidate for an effective and well-tolerated combination chemotherapy
can extend life by more than 19 months and was recommended for use in advanced bowel cancer by the National Institute of Health and Clinical Excellence in August last year Bowel cancer is the third most common form of cancer in the UK with 35,000 new cases diagnosed annually.
These recommendations mean that patients and clinicians will have access to combination chemotherapy
- the most effective treatment for patients with advanced colorectal cancer.
Before the development of combination chemotherapy
, patients with stage III breast cancer were treated with high dosages of radiation therapy, preceded or followed by a mastectomy.
The FDA Approved FUSILEV For Use In Combination Chemotherapy
With 5-Fluorouracil In The Palliative Treatment Of Patients With Advanced Metastatic Colorectal Cancer On April 29, 2011
Poster presentation, Session Experimental and Molecular Therapeutics - Combination Chemotherapy
1, Monday, April 20[sup.
Additionally, combination chemotherapy
resulted in a statistically significant improvement in survival compared to single agent, mainly 5-fluorouracil (5-FU)-based, chemotherapy (HR=0.
with docetaxel has shown a survival benefit compared to 5-FU/LV alone.
If the patient in our study was a chronic carrier, she should have had manifestations of acute West Nile encephalitis immediately following the first course of combination chemotherapy
, which was much more immunosuppressive than cyclophosphamide alone.
A group of 802 patients with newly diagnosed esophageal cancer from 42 European medical centers were randomized to treatment with either surgery or combination chemotherapy
using cisplatin and fluorouracil followed immediately by surgery (Lancet 359:1727-33, 2002).
Goserelin also proved more convenient, being given by monthly injection, while combination chemotherapy
required frequent lengthy visits to the hospital or clinic.
29] Other studies have shown that rates of cure and relapse-free survival following combination chemotherapy
were comparable to those of radiation therapy alone in early-stage Hodgkin's disease.
High-dose chemotherapy plus autologous bone marrow transplantation (HDC+ABMT) neither slows disease progression nor improves overall survival in low-risk patients with aggressive non-Hodgkin's lymphoma (NHL) treated with standard combination chemotherapy